{"vaccineGroup":[{"observationCode":"003","observationTitle":"Immunocompromised","contraindicationText":"Do not vaccinate if the patient is immunocompromised.","contraindicationGuidance":"","beginAge":"","endAge":""},{"observationCode":"007","observationTitle":"Pregnant","contraindicationText":"Do not vaccinate if the patient is pregnant.","contraindicationGuidance":"","beginAge":"","endAge":""},{"observationCode":"012","observationTitle":"Family history of altered immunocompetence","contraindicationText":"Do not vaccinate if the patient has a family history of altered immunocompetence","contraindicationGuidance":"","beginAge":"","endAge":""},{"observationCode":"031","observationTitle":"Tuberculosis","contraindicationText":"Do not vaccinate if the patient has active untreated tuberculosis.","contraindicationGuidance":"","beginAge":"","endAge":""},{"observationCode":"080","observationTitle":"Adverse reaction to vaccine component","contraindicationText":"Do not vaccinate if the patient has had an adverse reaction to a vaccine component.","contraindicationGuidance":"","beginAge":"","endAge":""},{"observationCode":"089","observationTitle":"Severe allergic reaction after previous dose of Varicella","contraindicationText":"Do not vaccinate if the patient has had a severe allergic reaction after a previous dose of Varicella vaccine.","contraindicationGuidance":"","beginAge":"","endAge":""},{"observationCode":"102","observationTitle":"Severe allergic reaction to gelatin","contraindicationText":"Do not vaccinate if the patient has had a severe allergic reaction to gelatin.","contraindicationGuidance":"","beginAge":"","endAge":""},{"observationCode":"107","observationTitle":"Severe allergic reaction to neomycin","contraindicationText":"Do not vaccinate if the patient has had a severe allergic reaction to neomycin.","contraindicationGuidance":"","beginAge":"","endAge":""},{"observationCode":"125","observationTitle":"Tetanus IG administration","contraindicationText":"Do not vaccinate if the patient has had Tetanus IG administered in the previous 3 months.","contraindicationGuidance":"","beginAge":"","endAge":""},{"observationCode":"126","observationTitle":"Hep A IG administration","contraindicationText":"Do not vaccinate if the patient has had Hepatitis A IG administered in the previous 3 months.","contraindicationGuidance":"","beginAge":"","endAge":""},{"observationCode":"127","observationTitle":"Hep B IG administration","contraindicationText":"Do not vaccinate if the patient has had Hepatitis B IG administered in the previous 3 months.","contraindicationGuidance":"","beginAge":"","endAge":""},{"observationCode":"128","observationTitle":"Rabies IG administration","contraindicationText":"Do not vaccinate if the patient has had Rabies IG administered in the previous 4 months.","contraindicationGuidance":"","beginAge":"","endAge":""},{"observationCode":"129","observationTitle":"Varicella IG administration","contraindicationText":"Do not vaccinate if the patient has had Varicella IG administered in the previous 5 months.","contraindicationGuidance":"","beginAge":"","endAge":""},{"observationCode":"130","observationTitle":"Measles prophylaxis IG administration - Standard","contraindicationText":"Do not vaccinate if the patient has had Measles IG at a standard dose (0.25 mL/kg) administered in the previous 5 months.","contraindicationGuidance":"","beginAge":"","endAge":""},{"observationCode":"131","observationTitle":"Measles prophylaxis IG administration - Immunocompromised Contact","contraindicationText":"Do not vaccinate if the patient has had Measles IG at an immunocompromised dose (0.5 mL/kg) administered in the previous 6 months.","contraindicationGuidance":"","beginAge":"","endAge":""},{"observationCode":"132","observationTitle":"RBC [adenine-saline added] blood transfusion","contraindicationText":"Do not vaccinate if the patient has received a blood transfusion of adenine-saline added RBCs in the previous 3 months.","contraindicationGuidance":"","beginAge":"","endAge":""},{"observationCode":"133","observationTitle":"Packed RBC blood transfusion","contraindicationText":"Do not vaccinate if the patient has received a blood transfusion of packed RBCs in the previous 6 months.","contraindicationGuidance":"","beginAge":"","endAge":""},{"observationCode":"134","observationTitle":"Whole blood transfusion","contraindicationText":"Do not vaccinate if the patient has received a whole blood transfusion in the previous 6 months.","contraindicationGuidance":"","beginAge":"","endAge":""},{"observationCode":"135","observationTitle":"Plasma/platelet products blood transfusion","contraindicationText":"Do not vaccinate if the patient has received a blood transfusion of plasma or platelet product in the previous 7 months.","contraindicationGuidance":"","beginAge":"","endAge":""},{"observationCode":"136","observationTitle":"Cytomegalovirus IGIV","contraindicationText":"Do not vaccinate if the patient has received Cytomegalovirus IGIV in the previous 6 months.","contraindicationGuidance":"","beginAge":"","endAge":""},{"observationCode":"137","observationTitle":"IGIV - Replacement therapy for immune deficiencies","contraindicationText":"Do not vaccinate if the patient has received IGIV (Replacement therapy for immune deficiencies) in the previous 8 months.","contraindicationGuidance":"","beginAge":"","endAge":""},{"observationCode":"138","observationTitle":"IGIV - Immune thrombocytopenic purpura treatment","contraindicationText":"Do not vaccinate if the patient has received IGIV (Immune thrombocytopenic purpura treatment (400 mg/kg IV)) in the previous 8 months.","contraindicationGuidance":"","beginAge":"","endAge":""},{"observationCode":"139","observationTitle":"IGIV - Postexposure varicella prophylaxis","contraindicationText":"Do not vaccinate if the patient has received IGIV (Postexposure varicella prophylaxis) in the previous 8 months.","contraindicationGuidance":"","beginAge":"","endAge":""},{"observationCode":"140","observationTitle":"IGIV - Immune thrombocytopenic purpura treatment","contraindicationText":"Do not vaccinate if the patient has received IGIV (Immune thrombocytopenic purpura treatment (1000 mg/kg IV)) in the previous 10 months.","contraindicationGuidance":"","beginAge":"","endAge":""},{"observationCode":"141","observationTitle":"IGIV - Kawasaki disease","contraindicationText":"Do not vaccinate if the patient has received IGIV (Kawasaki disease) in the previous 11 months.","contraindicationGuidance":"","beginAge":"","endAge":""},{"observationCode":"147","observationTitle":"T-lymphocyte [cell-mediated and humoral] - Complete defects","contraindicationText":"Do not vaccinate if the patient has complete cell-mediated or humoral T-lymphocyte defects (e.g., severe combined immunodeficiency [SCID] disease, complete DiGeorge syndrome).","contraindicationGuidance":"","beginAge":"","endAge":""},{"observationCode":"148","observationTitle":"T-lymphocyte [cell-mediated and humoral] - Partial defects","contraindicationText":"Do not vaccinate if the patient has partial cell-mediated or humoral T-lymphocyte defects (e.g., most patients with DiGeorge syndrome, Wiskott-Aldrich syndrome, ataxia- telangiectasia).","contraindicationGuidance":"","beginAge":"","endAge":""},{"observationCode":"150","observationTitle":"T-lymphocyte [cell-mediated and humoral] - interferon-gamma or interferon-alpha","contraindicationText":"Do not vaccinate if the patient has cell-mediated or humoral T-lymphocyte defects related to interferon-gamma or interferon-alpha.","contraindicationGuidance":"","beginAge":"","endAge":""},{"observationCode":"153","observationTitle":"Phagocytic function - Leukocyte adhesion defect, and myeloperoxidase deficiency","contraindicationText":"Do not vaccinate if the patient has a phagocytic function defect (e.g. leukocyte adhesion defect and myeloperoxidase deficiency).","contraindicationGuidance":"","beginAge":"","endAge":""},{"observationCode":"154","observationTitle":"HIV/AIDS - severely immunocompromised","contraindicationText":"Do not vaccinate if the patient has HIV/AIDS and is severely immunocompromised (See the CDC general recommendations for a definition of \u0022severely immunocompromised\u0022).","contraindicationGuidance":"","beginAge":"","endAge":""},{"observationCode":"156","observationTitle":"Generalized malignant neoplasm","contraindicationText":"Do not vaccinate if the patient has generalized malignant neoplasm.","contraindicationGuidance":"","beginAge":"","endAge":""},{"observationCode":"157","observationTitle":"Transplantation","contraindicationText":"Do not vaccinate if the patient received a transplant.","contraindicationGuidance":"","beginAge":"","endAge":""},{"observationCode":"158","observationTitle":"Immunosuppressive therapy","contraindicationText":"Do not vaccinate if the patient is undergoing immunosuppressive therapy. Immunosuppressive medications include those given to prevent solid organ transplant rejection, human immune mediators like interleukins and colony-stimulating factors, immune modulators like levamisol and BCG bladder-tumor therapy, and medicines like tumor necrosis factor alpha inhibitors and anti-B cell antibodies. ","contraindicationGuidance":"","beginAge":"","endAge":""},{"observationCode":"159","observationTitle":"Radiation therapy","contraindicationText":"Do not vaccinate if the patient is undergoing radiation therapy.","contraindicationGuidance":"","beginAge":"","endAge":""},{"observationCode":"168","observationTitle":"Chemotherapy","contraindicationText":"Do not vaccinate if the patient is undergoing chemotherapy, including 14 days before the start of therapy and 3 months after the completion of therapy.","contraindicationGuidance":"","beginAge":"","endAge":""}],"vaccine":null}